Rubicon Research acquires 85% stake in Arinna Lifesciences for ₹176 crore
Pharmaceutical company Rubicon Research Ltd on Wednesday (April 15) said it has acquired an 85% equity stake in Arinna Lifesciences Ltd for approximately ₹175.92 crore, marking its entry into the Indian central nervous system (CNS) formulations market. Arinna Lifesciences has a portfolio of over 60 brands in chronic therapies and is among the few domestic…
